432 related articles for article (PubMed ID: 31095738)
21. 1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis.
Wilmanski T; Barnard A; Parikh MR; Kirshner J; Buhman K; Burgess J; Teegarden D
Nutr Cancer; 2016 Oct; 68(7):1202-9. PubMed ID: 27552186
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.
Awolaran O; Brooks SA; Lavender V
Breast; 2016 Dec; 30():156-171. PubMed ID: 27750106
[TBL] [Abstract][Full Text] [Related]
23. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
24. Paget's "Seed and Soil" Theory of Cancer Metastasis: An Idea Whose Time has Come.
Akhtar M; Haider A; Rashid S; Al-Nabet ADMH
Adv Anat Pathol; 2019 Jan; 26(1):69-74. PubMed ID: 30339548
[TBL] [Abstract][Full Text] [Related]
25. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
26. The breast tumor microenvironment: role in cancer development, progression and response to therapy.
Mittal S; Brown NJ; Holen I
Expert Rev Mol Diagn; 2018 Mar; 18(3):227-243. PubMed ID: 29424261
[TBL] [Abstract][Full Text] [Related]
27. Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management.
Venetis K; Piciotti R; Sajjadi E; Invernizzi M; Morganti S; Criscitiello C; Fusco N
Cells; 2021 Jun; 10(6):. PubMed ID: 34199522
[TBL] [Abstract][Full Text] [Related]
28. Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.
Hu W; Zhang L; Dong Y; Tian Z; Chen Y; Dong S
Cell Mol Life Sci; 2020 Dec; 77(24):5149-5169. PubMed ID: 32556373
[TBL] [Abstract][Full Text] [Related]
29. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
30. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
Siclari VA; Guise TA; Chirgwin JM
Cancer Metastasis Rev; 2006 Dec; 25(4):621-33. PubMed ID: 17165131
[TBL] [Abstract][Full Text] [Related]
31. Metastasis dormancy in estrogen receptor-positive breast cancer.
Zhang XH; Giuliano M; Trivedi MV; Schiff R; Osborne CK
Clin Cancer Res; 2013 Dec; 19(23):6389-97. PubMed ID: 24298069
[TBL] [Abstract][Full Text] [Related]
32. Bone metastasis and the metastatic niche.
Ren G; Esposito M; Kang Y
J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
Coleman RE
Eur J Cancer; 2009 Jul; 45(11):1909-15. PubMed ID: 19447606
[TBL] [Abstract][Full Text] [Related]
34. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis.
Park SH; Keller ET; Shiozawa Y
Calcif Tissue Int; 2018 Feb; 102(2):152-162. PubMed ID: 29094177
[TBL] [Abstract][Full Text] [Related]
35. The bone microenvironment increases phenotypic plasticity of ER
Bado IL; Zhang W; Hu J; Xu Z; Wang H; Sarkar P; Li L; Wan YW; Liu J; Wu W; Lo HC; Kim IS; Singh S; Janghorban M; Muscarella AM; Goldstein A; Singh P; Jeong HH; Liu C; Schiff R; Huang S; Ellis MJ; Gaber MW; Gugala Z; Liu Z; Zhang XH
Dev Cell; 2021 Apr; 56(8):1100-1117.e9. PubMed ID: 33878299
[TBL] [Abstract][Full Text] [Related]
36. The bone marrow niche in support of breast cancer dormancy.
Walker ND; Patel J; Munoz JL; Hu M; Guiro K; Sinha G; Rameshwar P
Cancer Lett; 2016 Sep; 380(1):263-71. PubMed ID: 26546045
[TBL] [Abstract][Full Text] [Related]
37. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
Xia TS; Wang GZ; Ding Q; Liu XA; Zhou WB; Zhang YF; Zha XM; Du Q; Ni XJ; Wang J; Miao SY; Wang S
Breast Cancer Res Treat; 2012 Apr; 132(2):471-86. PubMed ID: 21638054
[TBL] [Abstract][Full Text] [Related]
38. New insights into the mechanisms of organ-specific breast cancer metastasis.
Lorusso G; Rüegg C
Semin Cancer Biol; 2012 Jun; 22(3):226-33. PubMed ID: 22504658
[TBL] [Abstract][Full Text] [Related]
39. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.
Sosnoski DM; Norgard RJ; Grove CD; Foster SJ; Mastro AM
Clin Exp Metastasis; 2015 Apr; 32(4):335-44. PubMed ID: 25749879
[TBL] [Abstract][Full Text] [Related]
40. Exploiting bone niches: progression of disseminated tumor cells to metastasis.
Muscarella AM; Aguirre S; Hao X; Waldvogel SM; Zhang XH
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
